Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease
Renato D. Lópes, Edimar Alcides Bocchi, Luis Eduardo Echeverría, Caroline Demacq et autres
Importance: The efficacy and safety of guideline-recommended treatments for heart failure (HF) are uncertain in patients with Chagas disease. Objective: To evaluate the efficacy and safety of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan in patients with HF with reduced ejection fraction due to …
us, br, co, in, ca, ar, mx, es, ch, gb (code pays fourni par la source)